Figure S3. Representative images of AO/EB staining of MCF7 and MB231 cells transfected with CYGB or control plasmid. The cells were cultured on coverslips, stained with AO/EB and photographed under a fluorescence microscope. (TIF 1275 kb
Figure S2. The drugs that were selected from the screen were validated using FACS. The MDA MB 231 re...
CREB3L1 protein expression in a panel of breast cancer cell lines. Cell lysates (50 μg protein/lane)...
Gene expression of invasive and mesenchymal markers in cell isolates. Mammary epithelial cell (MEC),...
Figure S2. (A) Semi-quantification of CYGB overexpression Western blot results. CYGB expression in v...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Figure S4. Inverse association between CYGB and (A) GLUT1 and (B) HXK2 expression in breast cancer. ...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Figure S6. Ectopic HXK2 expression partially reversed CYGB’s effect on proliferation and apoptosis. ...
Figure S3. ErbbB2 and Mek downregulate ΔNp63α in detached breast epithelial cells. MCF10A and MCF-Er...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S4. SGI and MS275 inhibit cell proliferation of bsMCF_luc, XtMCF, and LmMCF. (TIF 1491 kb
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S3. (A). Relative mRNA expression levels of FABP4, FABP5 and CD36 in breast cancer cell lines...
Figure S1. Effect of GNB4 overexpression on cell growth of 182R-6 and TAMR-1 cell lines (no drug tre...
Figure S2. The drugs that were selected from the screen were validated using FACS. The MDA MB 231 re...
CREB3L1 protein expression in a panel of breast cancer cell lines. Cell lysates (50 μg protein/lane)...
Gene expression of invasive and mesenchymal markers in cell isolates. Mammary epithelial cell (MEC),...
Figure S2. (A) Semi-quantification of CYGB overexpression Western blot results. CYGB expression in v...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Figure S4. Inverse association between CYGB and (A) GLUT1 and (B) HXK2 expression in breast cancer. ...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Figure S6. Ectopic HXK2 expression partially reversed CYGB’s effect on proliferation and apoptosis. ...
Figure S3. ErbbB2 and Mek downregulate ΔNp63α in detached breast epithelial cells. MCF10A and MCF-Er...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S4. SGI and MS275 inhibit cell proliferation of bsMCF_luc, XtMCF, and LmMCF. (TIF 1491 kb
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S3. (A). Relative mRNA expression levels of FABP4, FABP5 and CD36 in breast cancer cell lines...
Figure S1. Effect of GNB4 overexpression on cell growth of 182R-6 and TAMR-1 cell lines (no drug tre...
Figure S2. The drugs that were selected from the screen were validated using FACS. The MDA MB 231 re...
CREB3L1 protein expression in a panel of breast cancer cell lines. Cell lysates (50 μg protein/lane)...
Gene expression of invasive and mesenchymal markers in cell isolates. Mammary epithelial cell (MEC),...